Sandeep Jain – Akums Drugs& Pharmaceuticals Ltd

• Sandeep Jain founded Akums Drugs & Pharmaceuticals Ltd on April 1, 2004, with a vision to create a well-established pharmaceutical manufacturing company.
• Under Sandeep Jain's leadership, the company has grown into one of India's largest contract manufacturers of pharmaceuticals, catering to over 100 clients in more than 50 countries.
• Akums Drugs & Pharmaceuticals Ltd achieved WHO-GMP certification, ensuring compliance with international quality standards and enhancing its global market presence.
• Sandeep Jain has spearheaded the establishment of multiple state-of-the-art manufacturing facilities, increasing production capacity and improving operational efficiencies.
• The company has continuously invested in R&D, developing a diverse range of pharmaceutical products, including generic formulations and specialty drugs.
• Akums Drugs & Pharmaceuticals Ltd has fostered collaborations with various research institutions to enhance innovation and maintain competitiveness in the pharmaceutical sector.
• Through strategic planning and leadership, Sandeep Jain has successfully navigated challenges related to regulatory compliance and market competition.
• Sandeep Jain’s commitment to quality and sustainability has positioned the company as a leader in responsible manufacturing within the pharmaceutical industry.

Professional Experience

Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)

Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.

Official Email: Via Akums Drugs& Pharmaceuticals Ltd corporate communication desk.

Personal Contact: Not publicly disclosed.

What is Sandeep Jain's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).

How can I contact them?
Through Akums Drugs& Pharmaceuticals Ltd's official communication channels.

Is this an official profile?
No — independently created using public data.

This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.

Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.

Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: December 2025 · Published by Affluense AI (affluense.ai)